• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region

    10/27/25 5:00:00 PM ET
    $CTEV
    Real Estate
    Real Estate
    Get the next $CTEV alert in real time by email

    The investment expands Claritev's presence in the MENA region connecting Claritev's U.S. presence with Klaim's healthcare-fintech expertise from the Middle East.

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The investment will help fund the launch of a co-branded Payment Acceleration Service integrated within Claritev's extensive provider network, helping healthcare organizations gain faster and more predictable access to reimbursements across the U.S. and MENA regions.

    This investment and relationship strengthen Claritev's strategic expansion in the MENA region while supporting Klaim's expansion across the U.S. Together, the companies can combine Claritev's deep payor-provider infrastructure and ACE analytics platform with Klaim's proven payment-acceleration technology, aiming to set a new benchmark for liquidity access and operational efficiency in healthcare finance.

    The Claritev–Klaim Payment Acceleration platform is designed to allow eligible healthcare providers in the U.S. and MENA region to convert pending insurance claims into near-instant liquidity, reducing the typical 30–120-day reimbursement cycle.

    As part of the collaboration, Klaim will leverage Claritev's Advanced Code Editing (ACE) technology for claim coding intelligence to enable evaluation of claims qualified for funding.

    Additional key benefits to participating providers are anticipated to include:

    • Certainty of payment for qualifying claims and reduced risk of cash flow gaps due to denials or delays
    • Flexible usage as providers can choose the volume of claims to accelerate, based on their working capital needs
    • Reduced administrative burden as Klaim undertakes reconciliation and payor follow-up for accelerated claims
    • Scalable access, making the platform suitable for small clinics, large hospitals and multi-specialty networks

    "Our investment in Klaim reflects Claritev's commitment to modernizing provider cash flow and strengthening financial resilience across the healthcare system," said Will Mintz, Chief Strategy Officer at Claritev. "By combining Claritev's trusted provider relationships and ACE technology with Klaim's fintech infrastructure, we're helping providers get paid faster and operate with greater confidence."

    "This relationship is about unlocking liquidity at scale for healthcare providers," added Karim Dakki, Co-Founder & CEO of Klaim. "Together with Claritev, we're bringing a data-driven solution that turns delayed reimbursements into predictable cash flow, helping practices stay focused on delivering care rather than chasing payments. The investment also marks the beginning of Klaim's global restructuring, which is anticipated to bring together Klaim Middle East (under Klaim Holdings Limited) and Klaim, Inc. under a planned global holding company."

    About Claritev

    Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources and over 40 years of claims repricing experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose-built solutions that support all key players—including payors, employers, patients, providers and third parties—Claritev aims to make healthcare more accessible and affordable for all.

    Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

    About Klaim, Inc.

    Klaim, Inc. is healthcare-fintech company founded by Karim Dakki and Ghafoor Ahmad. Klaim enables healthcare providers to accelerate insurance reimbursements and improve cash flow predictability through proprietary AI-powered funding technology. By converting pending claims into cash within 24 hours, Klaim helps providers reduce administrative delays and strengthen financial resilience. Visit Klaim.com for more information.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251027220166/en/

    Media Relations



    Pamela Walker

    VP, Marketing

    Claritev

    781-895-3118

    [email protected]



    Investor Relations



    Todd Friedman

    VP, Investor Relations

    Claritev

    866-909-7427

    [email protected]

    Get the next $CTEV alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CTEV

    DatePrice TargetRatingAnalyst
    10/21/2025$74.00Neutral → Buy
    Citigroup
    5/29/2025$44.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $CTEV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Growth Officer Misencik Tiffani covered exercise/tax liability with 7,684 shares, decreasing direct ownership by 7% to 107,891 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    10/16/25 4:14:05 PM ET
    $CTEV
    Real Estate

    SVP, Chief Accounting Officer Albinson Brock was granted 2,825 shares (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    10/1/25 4:16:40 PM ET
    $CTEV
    Real Estate

    SEC Form 3 filed by new insider Albinson Brock

    3 - Claritev Corp (0001793229) (Issuer)

    10/1/25 4:16:16 PM ET
    $CTEV
    Real Estate

    $CTEV
    SEC Filings

    View All

    SEC Form 10-Q filed by Claritev Corporation

    10-Q - Claritev Corp (0001793229) (Filer)

    11/7/25 4:02:30 PM ET
    $CTEV
    Real Estate

    Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Claritev Corp (0001793229) (Filer)

    11/7/25 6:00:35 AM ET
    $CTEV
    Real Estate

    Claritev Corporation filed SEC Form 8-K: Other Events

    8-K - Claritev Corp (0001793229) (Filer)

    10/16/25 4:44:32 PM ET
    $CTEV
    Real Estate

    $CTEV
    Leadership Updates

    Live Leadership Updates

    View All

    Claritev Releases 2024 Corporate Responsibility Report

    Third annual report highlights the company's commitment to social and environmental stewardship Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the publication of its 2024 Corporate Responsibility Report. The 2024 report showcases the Company's strategic momentum in advancing its sustainability priorities during a pivotal year of transformation. The report emphasizes Claritev's continued focus on managing, tracking and disclosing its social and environmental performance, reinforcing its commitment to accountability and responsible

    7/16/25 9:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Appoints Mohamed Ramzy as SVP and General Manager, International to Lead Geographic Expansion; Signs with Halian to Support Regional Operations

    Strategic leadership and operational collaboration underscore Claritev's commitment to growth in the Middle East and international business development outside the US Claritev Corporation ("Claritev") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it is deepening its investment in the Middle East North Africa ("MENA") region and the market outside the United States with the appointment of new regional leadership and a strategic operational collaboration. These moves reflect Claritev's continued focus on expanding its footprint and delivering localized, high-impact healthcare technology soluti

    5/28/25 8:00:00 AM ET
    $CTEV
    Real Estate

    Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks

    HOLLYWOOD, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Great Speech, a national leader in virtual speech therapy, is proud to announce a new agreement with Claritev, formerly known as MultiPlan (NYSE:CTEV), a technology and data insights company focused on making healthcare more affordable, transparent and fair for all. This network participation agreement marks a major step forward in expanding access to high-quality, convenient, and personalized speech therapy services for individuals and families nationwide. Great Speech's innovative teletherapy services will now be available to health plan members accessing Claritev's MultiPlan and PHCS Networks. The initiative aims to eliminate traditio

    5/6/25 10:02:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Claritev Corporation Reports Third Quarter 2025 Results

    – Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024 – Net Loss of $69.8 million – Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024 (Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024) – Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2025. "We declared 2025 would be the Year of the Turn at Claritev. Our third quarter results and increased full year guidance demonstrate that w

    11/7/25 6:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region

    The investment expands Claritev's presence in the MENA region connecting Claritev's U.S. presence with Klaim's healthcare-fintech expertise from the Middle East. Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The investment will help fund the launch of a co-branded Payment Acceleration Service integrated within Claritev's extensive provider network, helping healthcare organizations gain faster and more predictable access to reimbursements across the U.S. and MENA regions. This investment and

    10/27/25 5:00:00 PM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its third quarter 2025 financial results on Friday, November 7, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to the following link: https://www.net

    10/16/25 7:00:00 AM ET
    $CTEV
    Real Estate

    $CTEV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Claritev upgraded by Citigroup with a new price target

    Citigroup upgraded Claritev from Neutral to Buy and set a new price target of $74.00

    10/21/25 7:13:03 AM ET
    $CTEV
    Real Estate

    Claritev upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Claritev from Neutral to Overweight and set a new price target of $44.00

    5/29/25 8:13:13 AM ET
    $CTEV
    Real Estate

    $CTEV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres., CEO & Executive Chair Dalton Travis bought $248,421 worth of shares (4,282 units at $58.02) (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    8/12/25 4:19:12 PM ET
    $CTEV
    Real Estate

    EVP, Chief Operating Officer Hogge Jerome bought $300,771 worth of shares (5,621 units at $53.51), increasing direct ownership by 7% to 90,023 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    8/11/25 4:21:15 PM ET
    $CTEV
    Real Estate

    EVP, Chief Operating Officer Hogge Jerome bought $349,250 worth of shares (12,500 units at $27.94), increasing direct ownership by 17% to 84,402 units (SEC Form 4)

    4 - Claritev Corp (0001793229) (Issuer)

    5/20/25 4:24:37 PM ET
    $CTEV
    Real Estate

    $CTEV
    Financials

    Live finance-specific insights

    View All

    Claritev Corporation Reports Third Quarter 2025 Results

    – Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024 – Net Loss of $69.8 million – Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024 (Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024) – Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the third quarter ended September 30, 2025. "We declared 2025 would be the Year of the Turn at Claritev. Our third quarter results and increased full year guidance demonstrate that w

    11/7/25 6:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call

    Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a healthcare technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, announced today that it will release its third quarter 2025 financial results on Friday, November 7, 2025, and hold its conference call that morning at 8:00 am Eastern Time. To join the conference call, please pre-register using the link below. Participants who pre-register will receive a calendar invitation with call access details including a unique PIN. Pre-registration may be completed at any time up to and following the call start time. To pre-register, go to the following link: https://www.net

    10/16/25 7:00:00 AM ET
    $CTEV
    Real Estate

    Claritev Corporation Reports Second Quarter 2025 Results

    Q2 2025 Revenues of $241.6 million, Net Loss of $62.6 million, and Adjusted EBITDA of $154.0 million (Adjusted EBITDA Margin of 63.8%) Full-year 2025 guidance updates to Revenue range (flat to +2% vs. 2024), Free Cash Flow range (usage of $20 million to generation of $20 million for year) and Capital Expenditures ($170 million to $180 million for year) Claritev Corporation ("Claritev" or the "Company") (NYSE:CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today reported financial results for the second quarter ended June 30, 2025. "Claritev is truly delivering in the year of The Turn. We returned to growth m

    8/6/25 6:00:00 AM ET
    $CTEV
    Real Estate